Dolby Laboratories $DLB Stock Holdings Trimmed by Voya Investment Management LLC

Key Points

• Voya Investment Management LLC significantly reduced its holdings in Dolby Laboratories, cutting its shares by 63.4% to 7,508 shares, valued at approximately $603,000.
• The company reported strong earnings with a 9.2% increase in revenue compared to the previous year, achieving $0.78 earnings per share against an estimate of $0.72.
• Dolby Laboratories recently increased its quarterly dividend to $0.33, representing an annualized dividend of $1.32 and a yield of 1.8%.

Voya Investment Management LLC decreased its holdings in Dolby Laboratories (NYSE:DLB - Free Report) by 63.4% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,508 shares of the electronics maker's stock after selling 13,031 shares during the quarter. Voya Investment Management LLC's holdings in Dolby Laboratories were worth $603,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Cetera Investment Advisers grew its position in Dolby Laboratories by 16.4% in the 4th quarter. Cetera Investment Advisers now owns 4,601 shares of the electronics maker's stock valued at $359,000 after buying an additional 648 shares in the last quarter. Two Sigma Advisers LP boosted its holdings in shares of Dolby Laboratories by 20.4% in the fourth quarter. Two Sigma Advisers LP now owns 29,500 shares of the electronics maker's stock valued at $2,304,000 after acquiring an additional 5,000 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Dolby Laboratories by 3.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 225,618 shares of the electronics maker's stock valued at $17,621,000 after acquiring an additional 6,640 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Dolby Laboratories by 6.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,657 shares of the electronics maker's stock valued at $442,000 after acquiring an additional 331 shares during the period. Finally, 111 Capital bought a new stake in Dolby Laboratories during the fourth quarter worth approximately $639,000. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Trading Down 0.2%

DLB stock opened at $71.43 on Friday. Dolby Laboratories has a one year low of $68.24 and a one year high of $89.66. The firm has a 50-day moving average of $73.13 and a two-hundred day moving average of $74.91. The firm has a market capitalization of $6.85 billion, a PE ratio of 26.17 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last released its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.06. The business had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were issued a $0.33 dividend. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. Dolby Laboratories's dividend payout ratio is presently 48.35%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DLB. Robert W. Baird initiated coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a "neutral" rating and a $74.00 price target for the company. Tigress Financial raised their target price on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Baird R W upgraded shares of Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Rosenblatt Securities restated a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, September 12th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.75.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the firm's stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $71.66, for a total transaction of $1,791,500.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,221,193.50. This trade represents a 17.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 99,366 shares of company stock valued at $7,293,963. 38.39% of the stock is currently owned by insiders.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.